Loading...
Identification of microRNAs involved in gefitinib resistance of non-small-cell lung cancer through the insulin-like growth factor receptor 1 signaling pathway
Multiple clinical and experimental studies have suggested that epidermal growth factor receptor tyrosine kinase inhibitors (EGFR-TKIs) may be effective at treating advanced non-small cell lung cancer (NSCLC), however, the molecular basis of primary resistance to EGFR-TKIs in NSCLC remains unclear. I...
Na minha lista:
| Udgivet i: | Exp Ther Med |
|---|---|
| Main Authors: | , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
D.A. Spandidos
2017
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5585727/ https://ncbi.nlm.nih.gov/pubmed/28912847 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/etm.2017.4847 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|